Natco Pharma Ltd on Wednesday said its Canadian subsidiary acquired 40 million shares in eGenesis Inc., a biotechnology company at the forefront of xenotransplantation focused on developing safe and effective human compatible organs for transplant, for USD 8 million. The city-based drug maker in a statement said the eGenesis Genome Engineering and Production platform is the only technology of its kind to comprehensively address cross-species molecular incompatibilities and viral risk via genetic engineering to improve the lives of patients in need of a transplant.

Natco Pharma Ltd周三表示，其加拿大子公司以800万美元收购了位于异种移植前沿的生物技术公司eGenesis Inc.的4000万股股份，该公司专注于开发安全有效的人体相容器官进行移植。这家总部位于城市的制药商在一份声明中表示，eGenesis基因组工程和生产平台是唯一一种通过基因工程全面解决跨物种分子不相容性和病毒风险的技术，以改善需要移植的患者的生活。

eGenesis is advancing development programs for kidney transplant, acute liver failure, and heart transplant, it said. 'We are excited to get involved with eGenesis, Inc. with respect to their pioneering work in xenotransplantation. We agree with the vision of eGenesis that xenotransplantation technology has the potential to end the global transplant shortage and transform the treatment of organ failure by eliminating waitlist mortality,' Rajeev Nannapaneni, Vice Chairman and CEO of Natco said.

eGenesis正在推进肾移植、急性肝衰竭和心脏移植的发展计划，它说我们很高兴能参与eGenesis，Inc.在异种移植方面的开创性工作。Natco副董事长兼首席执行官拉杰夫·纳纳帕内尼（RajeevNannapaneni）说，我们同意eGenesis的愿景，即异种移植技术有可能通过消除候补死亡率来结束全球移植短缺，并改变器官衰竭的治疗方式。

'We are thrilled to welcome Natco as an investor. Their support will be used in advancing our research and bringing our innovative therapies to market,' said Mike Curtis, CEO of eGenesis Inc. In March 2024, eGenesis announced the world's first porcine kidney transplant in a living patient. The transplant was authorized by the U.S.

“我们很高兴欢迎Natco成为投资者。eGenesis Inc.首席执行官迈克·柯蒂斯（MikeCurtis）说，他们的支持将用于推进我们的研究，并将我们的创新疗法推向市场。2024年3月，eGenesis宣布了世界上第一例活体猪肾移植。移植是由美国授权的。

Food & Drug Administration (FDA) under the Expanded Access pathway.(You can now subscribe to our Economic Times WhatsApp channel)(You can now subscribe to our Economic Times WhatsApp channel).

食品和药物管理局（FDA）根据扩大的访问途径。（您现在可以订阅我们的经济时报WhatsApp频道）（您现在可以订阅我们的经济时报WhatsApp频道）。